… amongst human COVID-19 pulmonary infections. We performed a high throughput screen
using hPSC-derived lung organoids and identified FDA-approved drug candidates, including …

… within the body, identifying the precise mechanism triggering … and explore potential
therapeutic approaches to mitigate the … As we mark the fifth year since the onset of the COVID-19 …

… resource for drug screening to identify candidate COVID-19 therapeutics. … hPSC-derived
LO and CO models that can be applied to screen for drug candidates for patients with COVID-19…

… for coronavirus disease 2019 (COVID-19) therapeutics [11,12]. … [45] utilized hPSC-derived
lung organoids to investigate the … this a tempting immune cell candidate for COVID-19 therapy. …

… of fibrotic lung organoids in order to identify aberrantly … Co-culture models of hPSC-derived
lung organoids and hPSC-derived … We expect that personalized therapy will also improve the …

… The coronavirus disease 2019 (COVID-19) pandemic is … of a variety of potential therapeutic
drugs 7 . However, these … viral RNA detection and infectious viral particle titration results. …

… The current COVID-19 pandemic is a perfect opportunity for … to show how these hPSC-derived
models can aid our … , hPSC-derived human somatic cells could be used as therapy…

… T cell therapies can be a powerful tool to treat COVID-19 … in COVID 19, it is empirical to
rationalize its use in COVID-19 … iPSCs derived airway epithelial cells and 3D-lung organoids …

… Against this backdrop, we highlight that the COVID-19 pandemic has fuelled the development
of … Identification of candidate COVID-19 therapeutics using hPSC-derived lung organoids …

… confirmed the potency of this therapy to prevent SARS-CoV-2 … conserved in our infected
organoid cocultures. These DEG … of mAbs as candidates for use as COVID-19 preventative …